Stock SNDL SNDL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company SNDL Inc.

Equities

SNDL

CA83307B1013

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 01:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
2.01 USD 0.00% Intraday chart for SNDL Inc. +6.91% +22.56%
02/04 Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana MT
02/04 Pot producers climb as recreational cannabis to go on Florida ballot RE

Business Summary

SNDL Inc. is a Canada-based private-sector liquor and cannabis retailer in Canada with retail banners, which include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Firesale Cannabis. Its segments include Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. The Liquor Retail segment includes the sale of wines, beers and spirits through liquor stores. The Cannabis Retail segment includes the private sale of recreational cannabis through and franchise retail cannabis stores. The Cannabis Operations segment includes the cultivation, distribution and sale of cannabis for the adult-use and medical markets domestically and for export, and providing cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Investments segment includes the deployment of capital to investment opportunities. Its cannabis brand portfolio includes Top Leaf, Vacay, Grasslands and others.

Number of employees: 2,516

Sales per Business

USD in Million2022Weight2023Weight Delta
Liquor Retail
63.7 %
355 64.9 % 429 63.7 % +20.81%
Cannabis Retail
31.9 %
158 28.9 % 215 31.9 % +36.04%
Cannabis
9.6 %
34 6.2 % 65 9.6 % +89.13%
Corporate
-5.2 %
0 0.0 % -35 -5.2 % -

Sales per region

USD in Million2022Weight2023Weight Delta
Canada
100.0 %
547 100.0 % 673 100.0 % +23.11%

Managers

Managers TitleAgeSince
Zachary George CEO
 Chief Executive Officer 45 27/19/27
Alberto Paredero-Quiros DFI
 Director of Finance/CFO 51 01/23/01
Sophie Pilon IRC
 Investor Relations Contact - -
Deanna Garand HRO
 Human Resources Officer 41 01/22/01
Ryan Hellard PRN
 Corporate Officer/Principal 35 01/18/01
Marcie Kiziak PRN
 Corporate Officer/Principal 43 31/22/31
A. Robson PRN
 Corporate Officer/Principal 35 17/23/17
Matthew Husson LAW
 General Counsel 43 01/23/01

Members of the board

Members of the board TitleAgeSince
Frank Krasovec BRD
 Director/Board Member 80 17/23/17
Gregory Turnbull BRD
 Director/Board Member 69 01/18/01
Zachary George CEO
 Chief Executive Officer 45 27/19/27
Greg Mills CHM
 Chairman 61 01/19/01
Lori Ell BRD
 Director/Board Member 57 07/21/07
Bryan Pinney BRD
 Director/Board Member 71 18/19/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 262,775,853 259,480,636 ( 98.75 %) 0 98.75 %

Shareholders

NameEquities%Valuation
ETF Managers Group LLC
2.667 %
7,016,448 2.667 % 14 M $
Global X Management Co. LLC
1.912 %
5,031,312 1.912 % 10 M $
Citadel Securities GP LLC
0.5671 %
1,491,957 0.5671 % 3 M $
Morgan Stanley Capital Services LLC
0.4310 %
1,133,842 0.4310 % 2 M $
AdvisorShares Investments LLC
0.3076 %
809,212 0.3076 % 2 M $
Capital Ventures International
0.3018 %
794,050 0.3018 % 2 M $
Zachary George
0.2387 %
627,876 0.2387 % 1 M $
A. Robson
0.2277 %
599,136 0.2277 % 1 M $
Group One Trading LP
0.2055 %
540,561 0.2055 % 1 M $
Invesco Capital Management LLC
0.1912 %
503,073 0.1912 % 1 M $

Holdings

NameEquities%Valuation
NOVA CANNABIS INC.
62.49%
 35,750,000 62.49% 47,547,500 $
INDIVA LIMITED
8.56%
 15,938,500 8.56% 956,310 $

Company contact information

SNDL, Inc.

919–11th Avenue SW Suite 300

T2R 1P3, Calgary

+844 879 8337

http://www.sndl.com
address SNDL Inc.(SNDL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for SNDL Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.744 CAD
Average target price
4.92 CAD
Spread / Average Target
+79.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SNDL INC. Stock SNDL Inc.
+22.56% 529M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 234B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SNDL Stock
  4. Company SNDL Inc.